UPDATE: Cytosorbents (CTSO) Tops Q2 EPS View

(Updated - August 14, 2015 8:01 AM EDT) (EPS corrected)

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of $0.05, which was better than the analyst estimate of ($0.11). Revenue for the quarter came in at $733 thousand versus the consensus estimate of $910 thousand.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• UBS cuts KOSPI target by nearly 10% to reflect higher rates
• DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2